Merck

Merck is a multinational pharmaceutical company focused on developing and manufacturing medications across numerous therapeutic areas and disease states. The company has increasingly focused on adopting artificial intelligence to advance drug discovery and development—a shift reflecting broader pharmaceutical industry interest in using AI to accelerate research timelines and reduce development costs.

In recent partnerships, including a multi-target discovery collaboration and license agreement with AI-focused biotech startup Protillion valued at up to $510 million, Merck has positioned AI-powered drug design as central to its innovation strategy. This emphasis on AI in pharmaceutical research reflects both the potential of machine learning to identify promising drug candidates and the competitive pressure that exists across the industry to streamline traditionally lengthy and expensive discovery processes.